Gefitinib (250mg).

The drug gefitinib 250 mg belongs to a special category of anticancer drugs known as tyrosine kinase inhibitors (TKIs). It differs from the classical chemotherapy which targets any rapidly growing cells in the body because it targets cancer cells containing EGFR gene mutation.
GEFISTERIS 250 contains gefitinib 250 mg as its main drug ingredient. This makes the drug effective against cancer because the mechanism of action is specific targeting of pathways involved in signaling for tumor cell growth and proliferation hence preventing them from obtaining the growth factors required for survival.

This drug, gefitinib, comes in the form of a tablet which can be taken orally, unlike the classical chemotherapy treatment which involves an intravenous route.

 

What is Gefitinib 250 mg Used For?

Primary Indication

Tab gefitinib 250 mg is primarily prescribed for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients whose tumors have specific EGFR mutations. These mutations are detected through genetic testing of tumor tissue or blood samples.

Specific Uses Include:

• First-line treatment for EGFR mutation-positive NSCLC
• Treatment of patients who have received previous chemotherapy
• Management of advanced lung cancer that has spread to other parts of the body
• Maintenance therapy after initial response to treatment
  Tab gefitinib 250 mg uses are specifically limited to patients with confirmed EGFR mutations, which is why genetic testing is essential before starting treatment.

 

Is Gefitinib a Chemotherapy?

This is a common question, and the answer is nuanced. Gefitinib is not traditional chemotherapy . Instead, it's classified as a targeted therapy or biological therapy .

Gefitinib works only in patients whose tumors carry specific EGFR mutations, making genetic testing essential before treatment.Because it is a targeted therapy, Gefitinib is often associated with fewer severe side effects than conventional chemotherapy.

Key Differences:

Traditional Chemotherapy: - Attacks all rapidly dividing cells (both cancerous and healthy)

• Often causes severe side effects like hair loss and severe nausea
• Given in cycles with rest periods
  Gefitinib (Targeted Therapy): - Specifically targets cancer cells with EGFR mutations
• Generally has fewer and less severe side effects
• Taken continuously as a daily oral tablet

While both are cancer treatments, gefitinib's targeted approach typically results in better tolerability and quality of life for patients.

 

Gefitinib 250 mg Price in India

Tab Gefitinib 250 mg Price in India

The gefitinib 250 mg price in India varies depending on the brand and pharmacy. GEFISTERIS 250 by Steris Healthcare is competitively priced to ensure accessibility for patients who need this life-saving medication.Gefitinib should only be taken under the supervision of a qualified oncologist after confirmation of EGFR mutation status.
Approximate pricing range: - Generic gefitinib 250 mg tablets price in India: ₹3,500 - ₹8,000 per 10 tablets

• Monthly treatment cost: ₹10,500 - ₹24,000 (for 30 tablets)
• Branded versions may cost more
  GEFISTERIS 250 offers excellent value while maintaining pharmaceutical quality standards. Many patients find that the tab gefitinib 250 mg price in India through Steris Healthcare is more affordable than imported brands while delivering equivalent therapeutic benefits.

Cost Considerations:

• Prices may vary by region and pharmacy
• Some insurance plans cover gefitinib treatment
• Patient assistance programs may be available
• Bulk purchasing may offer savings

 

Gefitinib 250 mg Brands in India

Several pharmaceutical companies manufacture gefitinib 250 mg brands in India , including:

• GEFISTERIS 250 (Steris Healthcare) - High-quality Indian pharmaceutical brand
• Other generic manufacturers
• Imported brands
  GEFISTERIS 250 by Steris Healthcare stands out for its:
• Strict quality control standards
• Bioequivalence to reference products
• Competitive pricing
• Reliable supply chain
• Strong pharmaceutical credentials

When choosing between gefitinib brands, consider factors like manufacturer reputation, pricing, availability, and your oncologist's recommendation.

 

When to Take Gefitinib: Best Time to Take Gefitinib Tablets

Optimal Timing

The best time to take gefitinib tablets is:

• Once daily , at approximately the same time each day
• With or without food - gefitinib can be taken on an empty stomach or with meals
• Preferably at a time you'll remember to maintain consistency

Important Timing Guidelines:

1. Choose a convenient time you can maintain daily (morning or evening)
2. Set a reminder to avoid missing doses
3. Take with water - swallow the tablet whole
4. If you miss a dose , take it as soon as you remember unless it's close to your next scheduled dose
5. Never double up doses to make up for a missed one

Consistency in timing helps maintain stable drug levels in your bloodstream, maximizing treatment effectiveness.

 

Gefitinib 250 mg Dosage Guide

Standard Dosage

The typical recommended dose is:

• One 250 mg tablet once daily - Continuous treatment until disease progression or unacceptable toxicity occurs

Dosage Adjustments

Your oncologist may adjust your dose based on:

• Side effect severity - dose may be temporarily stopped or reduced
• Liver or kidney function - may require monitoring and adjustment
• Drug interactions - other medications may affect gefitinib levels
• Individual tolerance - some patients may need dose modifications
  Never adjust your gefitinib dosage without consulting your oncologist.

 

Who Should Not Take Gefitinib?

Contraindications and Precautions

Gefitinib should not be taken by:

1. Patients without EGFR mutations - unlikely to benefit from treatment
2. Pregnant women - can cause fetal harm
3. Those with severe allergic reactions to gefitinib or its ingredients
4. Breastfeeding mothers - may harm nursing infants

Use with Caution in:

• Patients with pre-existing liver disease
• Those with lung conditions beyond cancer
• Individuals with gastrointestinal disorders
• Patients taking multiple medications that may interact
• Those with heart conditions

Always disclose your complete medical history to your oncologist before starting gefitinib treatment.

 

How Long Can You Take Gefitinib?

The duration of gefitinib treatment varies significantly between patients:

Treatment Duration Factors:

• Treatment response - patients who respond well may continue for years
• Disease progression - treatment typically continues until cancer progresses
• Side effect tolerance - severe adverse effects may require discontinuation
• Development of resistance - cancer cells may eventually develop resistance to gefitinib
  Average treatment duration: Many patients take gefitinib for 12-24 months, though some continue for several years with good response and tolerability.
  Long-term use: Gefitinib can be taken safely for extended periods under medical supervision with regular monitoring.

 

What Does Gefitinib Do for Cancer?

Mechanism of Action

Gefitinib 250 mg tablet uses a sophisticated mechanism to fight cancer:

1. Blocks EGFR signaling - Prevents the EGFR protein from sending growth signals
2. Stops cancer cell division - Without growth signals, cancer cells stop multiplying
3. Induces cell death - Cancer cells may undergo programmed death (apoptosis)
4. Prevents new blood vessel formation - Limits tumor blood supply
5. Reduces metastasis - Decreases cancer's ability to spread

Clinical Benefits:

• Tumor shrinkage in many patients
• Slowed disease progression - Extended survival compared to chemotherapy in EGFR-positive patients
• Improved quality of life - Symptom relief from cancer-related complications

 

Can Gefitinib Shrink Tumors?

Yes, gefitinib can effectively shrink tumors in patients with EGFR-positive NSCLC.

Clinical Evidence:

• Response rates: 60-80% of EGFR mutation-positive patients show tumor response
• Tumor shrinkage: Many patients experience significant reduction in tumor size
• Rapid response: Some patients notice improvement within weeks
• Duration of response: Tumor control often lasts 12+ months

Monitoring Response:

Your oncologist will track treatment effectiveness through:

• Regular CT or PET scans
• Tumor marker blood tests
• Physical examinations
• Symptom assessment

 

Gefitinib 250 mg Side Effects

Common Side Effects

Gefitinib 250 mg side effects typically include:
Skin-related (most common): - Acne-like rash (affects 50-80% of patients)

• Dry skin
• Itching
• Nail changes
  Gastrointestinal: - Diarrhea (common but usually manageable)
• Nausea
• Loss of appetite
• Mouth sores
  Other common effects: - Fatigue
• Eye inflammation or dryness
• Elevated liver enzymes

Serious Side Effects (Rare)

Contact your doctor immediately if you experience:

• Severe breathing problems or new shortness of breath
• Severe or persistent diarrhea
• Eye pain or vision changes
• Signs of liver problems (yellowing skin/eyes, dark urine)
• Severe skin reactions

Managing Side Effects

Most side effects are manageable with:

• Moisturizing creams for skin issues
• Anti-diarrheal medications
• Dietary adjustments
• Dose modifications if needed

 

Does Gefitinib Cause Hair Loss?

Good news: Gefitinib typically does NOT cause significant hair loss , which is a major advantage over traditional chemotherapy.

Hair-Related Effects:

• Minimal hair thinning may occur in some patients
• Hair texture changes are possible but uncom

 

Can I Stop Taking Gefitinib Suddenly?

No, you should never stop taking gefitinib suddenly without consulting your oncologist first. This is a critical safety consideration for anyone on targeted cancer therapy.

Why Sudden Discontinuation is Risky:

1. Disease Progression Risk - Cancer cells may rapidly proliferate once treatment stops

   • Tumors that were controlled may begin growing again
   • Disease may progress to a more advanced stage

2. Loss of Treatment Effectiveness - Stopping and restarting may affect how well gefitinib works

   • Cancer cells may develop resistance during treatment gaps
   • You may lose the therapeutic benefit achieved

3. Missed Opportunity - Even if side effects are challenging, dose adjustments or supportive care may help

   • Premature discontinuation may eliminate your best treatment option

 

How Effective is Gefitinib 250 mg for Lung Cancer?

Gefitinib 250 mg is highly effective for EGFR mutation-positive non-small cell lung cancer (NSCLC) , representing one of the most significant advances in lung cancer treatment.Gefitinib is specifically developed for advanced non-small cell lung cancer and is not intended for all cancer types.

Clinical Effectiveness Data:

Response Rates:

• EGFR-positive patients: 60-80% experience tumor shrinkage or stabilization
• Overall response rate: Approximately 70% in first-line treatment
• Disease control rate: Up to 85% of patients achieve disease control (response or stable disease)

Survival Benefits:

• Progression-free survival: Average 9-13 months (compared to 5-6 months with chemotherapy)
• Overall survival: Many patients live 2-3+ years with sequential targeted therapies
• Quality of life: Significantly better than traditional chemotherapy

Effectiveness by Patient Group:

Highest Effectiveness: - EGFR exon 19 deletions - Response rates up to 80%

• EGFR L858R mutations - Response rates 60-70%
• Asian ethnicity - Generally higher response rates
• Non-smokers - Better outcomes than smokers
• Female patients - Slightly better responses in some studies
  Lower Effectiveness: - Wild-type EGFR (no mutations) - Only 10-15% response rate
• Resistant mutations (T790M) - Primary resistance, requires alternative TKIs
• Extensive metastases - May have shorter response duration

Comparison to Other Treatments:

Treatment	Response Rate	Progression-Free Survival	Quality of Life
Gefitinib (EGFR+)	60-80%	9-13 months	High
Chemotherapy	30-40%	5-6 months	Moderate
Best supportive care	<10%	2-3 months	Variable

 

What is the Success Rate of Gefitinib Treatment?

The success rate of gefitinib treatment depends on how we define "success":

Objective Response Success:

• Complete response (tumor disappears): 3-5% of patients
• Partial response (tumor shrinks ≥30%): 55-75% of patients
• Stable disease (no growth): 15-25% of patients
• Overall success rate (response + stable disease): 75-90% in EGFR-positive patients

Long-Term Success Indicators:

• 1-year survival rate: 70-80% of patients
• 2-year survival rate: 45-60% of patients
• 3-year survival rate: 25-35% of patients
• Some patients survive 5+ years with sequential therapies

Factors Affecting Success:

Positive factors: - Specific EGFR mutation type (exon 19 deletion best)

• Early-stage disease at diagnosis
• Good performance status
• Non-smoking history
• No brain metastases
  Challenging factors: - Presence of resistant mutations
• Extensive metastatic disease
• Poor organ function
• Previous treatment failure
• Smoking history

 

Why Choose GEFISTERIS 250 by Steris Healthcare?

Quality Assurance:

Steris Healthcare maintains rigorous pharmaceutical standards:

• GMP-certified manufacturing facilities
• Bioequivalence studies confirming therapeutic equivalence
• Batch-to-batch consistency ensuring reliable efficacy
• Quality control testing at multiple production stages
• Regulatory compliance with Indian pharmaceutical standards

 

Conclusion

GEFISTERIS 250 (250mg gefitinib) by Steris Healthcare is an effective development in lung cancer drugs for those patients who suffer from non-small cell lung cancer that is positive for EGFR. The effectiveness of the drug has reached up to 60-80%, which is much better than the conventional chemotherapy.

 

Frequently Asked Questions (FAQ)

1. Does Gefitinib 250 mg require a prescription?

Yes. Gefitinib is a specialized targeted cancer medication. It must only be taken under the direct supervision of an oncologist who has confirmed your EGFR mutation status through genetic testing. Never attempt to purchase or take this medication without a valid prescription.

2. Can I take GEFISTERIS 250 if I don't have an EGFR mutation?

No. Gefitinib is specifically designed to target the EGFR protein. Clinical studies show that it is significantly less effective in patients who do not have these specific mutations. Your oncologist will perform a biopsy or liquid biopsy to determine if you are a candidate for this therapy.

3. What should I do if I miss a dose of Gefitinib?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed one entirely. Do not take two tablets at once to make up for a missed dose, as this increases the risk of side effects.

4. How long does it take for Gefitinib to start working?

Many patients begin to notice improvements in symptoms like coughing or shortness of breath within a few weeks of starting treatment. However, objective tumor shrinkage is typically confirmed during follow-up CT or PET scans, which are usually scheduled every 2 to 3 months.

5. Can I consume alcohol while on Gefitinib?

It is best to avoid or strictly limit alcohol while taking Gefitinib. Alcohol can put additional stress on the liver, and because Gefitinib can sometimes affect liver enzyme levels, combining the two may complicate monitoring your health. Always consult your doctor for specific advice based on your liver function tests.

6. Will I lose my hair while taking Gefitinib?

Unlike traditional chemotherapy, Gefitinib is a targeted therapy and typically does not cause significant hair loss. Some patients may experience minor thinning or changes in hair texture, but it is rarely the total hair loss associated with standard IV chemotherapy.

7. Why is sun protection important while on this medication?

Gefitinib can make your skin more sensitive to sunlight (photosensitivity). This means you may get sunburned more easily. It is highly recommended to use a broad-spectrum SPF 50+ sunscreen, wear protective clothing, and avoid prolonged direct sun exposure during your treatment.

8. How should I store GEFISTERIS 250 tablets?

Store your medication in a cool, dry place, away from direct sunlight and moisture. Keep the tablets in their original packaging and ensure they are stored out of the reach of children and pets. Do not store them in the bathroom or near kitchen appliances that generate heat.

9. What are the signs of a serious reaction to Gefitinib?

Seek immediate medical attention if you experience:

• Sudden, new, or worsening shortness of breath or cough.
• Signs of liver problems (yellowing of the skin or eyes, dark urine, or abdominal pain).
• Severe or uncontrollable diarrhea.
• Severe eye pain, redness, or vision changes.
• Signs of a severe allergic reaction (swelling of the face, lips, or throat).

10. Can I switch from a different brand to GEFISTERIS 250?

GEFISTERIS 250 is manufactured to meet strict pharmaceutical standards. However, before switching brands, always consult your oncologist or pharmacist to ensure you are continuing the correct dosage and to discuss any specific requirements for your ongoing treatment plan.